Join us on Tuesday, May 12 at 12 p.m. ET, for an online discussion with Prof. Ruth Arnon, from Weizmann’s Department of Immunology, who has spearheaded a universal influenza vaccine.
As a renowned immunologist, Prof. Arnon previously co-developed a multiple sclerosis (MS) drug that commands a third of the market worldwide. She is now undergoing the third and final phase in the clinical trial process for an influenza vaccine, which would protect people from the flu for many years and against multiple strains. Results are expected later this year.
Since the flu changes every year, new vaccines continually have to be made and developed for the current strain. After working on this project for two decades, Prof. Arnon and colleagues now have a vaccine they believe will be ready to go public, upon approval from regulators.
The event and question and answer period will be moderated by Dr. Arthur Slutsky, Keenan Chair in Medicine at St. Michael’s Hospital and Professor of Medicine, Surgery and Biomedical Engineering at the University of Toronto. Dr. Slutsky also serves on the Weizmann Canada Board of Directors.
We are so grateful for your support and participation.
DATE | Tuesday, May 12, 2020
TIME | Join by 11:50 a.m. ET, presentation will begin at 12:00 p.m. ET (noon)
LOCATION | Online via Zoom (details to be provided upon registration)
Please note that turning on your video camera for the event is optional. We hope you will join us in the capacity in which you feel comfortable.
This is a free event, but space is limited.